CuraGen Corporation - SWOT Analysis

Datamonitor's CuraGen Corporation Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

CuraGen is a biopharmaceutical company that develops a pipeline of protein, antibody, and small molecule therapeutic products. The company is engaged in the development of pharmaceutical products in the areas of oncology, inflammatory disease and diabetes. CuraGen is headquartered in Branford, Connecticut and employed 255 people as of December 2006. The company recorded revenues of $40 million during the fiscal year ended December 2006, an increase of 68% over 2005. The operating loss of the company was $59 million during 2006 compared to $74 million in 2005. The net loss in fiscal year 2006 was $60 million compared to $73 million in 2005.

Scope of the Report

• Provides all the crucial company information required for business and competitor intelligence needs
• Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to Purchase

• Support sales activities by understanding your customers' businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors' business structure, strategy and prospects
• Obtain the most up to date company information available